AnalysisNews

BCTX today

$3.33-$0.08 (-2.35%)close Nov 16, 2026

Trend

DailyUptrend (starting)

4 hourStrong Bullish

1 hourSymmetric Triangle

15 minStrong Bearish

5 minStrong Bullish

Daily trend turns down below $2.60

Key levels

Resistance$3.67

Resistance$3.36

Support$2.95

Support$2.60

Latest news & SEC filings

NewsBriaCell Therapeutics receives annual honor for its cancer treatment work

ProductBriaCell to Show ESMO 2026 Poster on Blood Immune Marker Tied to Results in Advanced Breast Cancer

All BCTX news →

About BriaCell Therapeutics

BriaCell Therapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer. Its lead candidate, Bria-IMT, is a whole-cell immunotherapy being tested in combination with an immune checkpoint inhibitor for metastatic breast cancer. The company also develops personalized off-the-shelf immunotherapies, including Bria-OTS and candidates for prostate, ovarian, and melanoma cancers. Its customers are cancer patients, and it operates primarily in the United States.

Based on the company's 10-K filed Oct 28, 2026.

Nasdaq · Healthcare

BriaCell Therapeutics Corp. (BCTX)

$3.33-0.08 (-2.35%)
HOLDGrade: CRisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
3.213.413.623.823.33Oct 14Oct 22Oct 30Nov 9
High3.35
Low3.33
Open3.33
Volume2K
Avg Vol56K
VWAP3.34
30d High4.02
30d Low3.01
30d Chg-17.16%

What Is the Price Target for BCTX?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $3.39Upside: +0.0%Confidence: 20%Method: No Coverage

Is BCTX a Buy or Sell Right Now?

42
Investability Score
HOLD12-18 months

Test your own strategy on BCTX

Describe your strategy in plain words, then scan, alert, backtest and paper trade it on BCTX with SEPT’s own market data.

Start Free Trial →

Is BCTX Overvalued or Undervalued?

Valuation Verdict

N/A

Methods Used

N/A

Fair Value

$N/A

5

Moat Score

NONE

1/9

Piotroski Score

N/A

Altman Z-Score

What Is Smart Money Doing with BCTX?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See Smart Money Data →

BCTX Growth Story

Revenue YoY

N/A%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-42.38%

FCF Growth YoY

N/A%

Revenue Trend

UNKNOWN

Dark Pool Trades for BCTX

PREVIEW

Recent off-exchange (dark pool) prints for BCTX: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

TimePriceSizeValueSide
19:43:17$3.361,000$$3KSELL
15:31:18$3.304,328$$14KSELL
17:18:19$3.461,249$$4KBUY
15:20:04$3.4120,602$$70KSELL
20:19:02$3.571,000$$4KSELL

5 dark pool trades shown · $$96K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for BriaCell Therapeutics Corp. (BCTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

Your strategy, tested before real money.

Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

Try SEPT Free for 7 Days →

BCTX — frequently asked questions

What is BCTX stock price today?

BriaCell Therapeutics Corp. (BCTX) is at $3.33, down 2.35% (-$0.08) at the Nov 16, 2026 close.

Why is BCTX stock moving today?

Latest BCTX news — Nov 6, 2026: BriaCell Therapeutics receives annual honor for its cancer treatment work · Oct 23, 2026: BriaCell to Show ESMO 2026 Poster on Blood Immune Marker Tied to Results in Advanced Breast Cancer

Did BCTX beat earnings?

BCTX last reported on Jun 9, 2026: EPS -$0.99.

What is BCTX's P/E ratio?

BCTX trades at a P/E of 1.5 vs a Healthcare average of 17.9.

What are BCTX support and resistance levels?

Support: $2.95, $2.60. Resistance: $3.36, $3.67, $4.08.

What are insiders doing with BCTX?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on BCTX?

Nov 6, 2026: BriaCell Therapeutics receives annual honor for its cancer treatment work · Oct 23, 2026: BriaCell to Show ESMO 2026 Poster on Blood Immune Marker Tied to Results in Advanced Breast Cancer